English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52869482    Online Users :  739
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"chou cheng yang"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-10 of 104  (11 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2025-07-03 多無人機輔助行動邊緣運算系統之任務卸載與本地計算效能優化方案 周呈陽; Chou, Cheng-Yang
臺大學術典藏 2022-06-17T02:03:04Z Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study Chou, Cheng-Yang; WEN-FANG CHENG; Chen, Min-Yu; Lin, Hao; Ho, Chih-Ming; Hung, Yao-Ching; Huang, Lee-Wen; Wang, Po-Hui; Yu, Mu-Hsien; Huang, Yu-Fang
嘉南藥理大學 2021 COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta 3 through the NF-kappa B/IGFBP2 axis in ovarian cancer cells Wu, Yi-Hui; Huang, Yu-Fang; Chang, Tzu-Hao; Chen, Chien-Chin; Wu, Pei-Ying; Huang, Soon-Cen; Chou, Cheng-Yang
國立成功大學 2020-07-14 Real-world Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-line or Relapse Therapy (ROBOT): 8-year Experience 黃于芳; Huang, Yu-Fang; Wu, Pei-Ying;Cheng, Ya-Min;Shen, Meng-Ru;Chen, Yi-Chun;Chou, Cheng-Yang
國立交通大學 2020-03-03 Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment Chou, Cheng-Yang; Huang, Chia-Yen; Chen, Chien-Chin; Wu, Yi-Hui; Huang, Yu-Fang
國立成功大學 2020-02-21 Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesions 邱文泰; CHIU, WEN-TAI;Huang, Ho-Kai;Lin, Yi-Hsin;Chang, Heng-Ai;Lai, Yi-Shyun;Chen, Ying-Chi;Huang, Soon-Cen;Chou, Cheng-Yang
嘉南藥理大學 2020 Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment Wu, Yi-Hui; Huang, Yu-Fang; Chen, Chien-Chin; Huang, Chia-Yen; Chou, Cheng-Yang
國立成功大學 2019-04-01 Akt Inhibitor SC66 Promotes Cell Sensitivity to Cisplatin in Chemoresistant Ovarian Cancer Cells Through Inhibition of COL11A1 Expression 黃于芳; Huang, Yu-Fang; Wu, Yi-Hui;Chen, Chien-Chin;Chou, Cheng-Yang
嘉南藥理大學 2019 Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression Wu, Yi-Hui; Huang, Yu-Fang; Chen, Chien-Chin; Chou, Cheng-Yang
國立成功大學 2019 A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy 黃于芳; Huang, Yu-Fang; Kuo, MacUs Tien;Liu, Yi-Sheng;Cheng, Ya-Min;Wu, Pei-Ying;Chou, Cheng-Yang

Showing items 1-10 of 104  (11 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page